| |
|
|
Session 103
Poster Presentations HBV: Epidemiology, Natural History and Treatment in Co-Infected Patients Wednesday 1:30 - 3:30 pm Hall B |
| 820 | Prevalence of Occult Hepatitis B Infection in HIV-infected Patients: Analysis of a Geographically Distributed ACTG Cohort K. E. Sherman*1, N. Shire2, S. Rouster1, N. Rajicic3 1Univ of Cincinnati, OH; 2Johns Hopkins Univ, Baltimore, MD; and 3Harvard Sch of Public Hlth, Boston, MA |
| 821 | Isolated Antibody to Hepatitis B Core Antigen (anti-HBc) in a U.S. HIV+ Cohort R. T. Gandhi*1, A. Wurcel1, H. Lee1, M. Boczanowski1, R. Gerwin1, C. Corcoran1, Z. Szczepiorkowski1, S. Toner1, B. McGovern2, P. Sax3, C. Ukomadu3 1Massachusetts Gen Hosp, Boston; 2Lemuel Shattuck Hosp, Boston, MA; and 3Brigham and Women's Hosp, Boston, MA |
| 822 | The Impact of Prior Hepatitis B Virus Infection on Histologic Lesions in HIV and Hepatitis C Virus Co-infected Patients Y. Benhamou*, R. P. Myers, V. Thibault, S. Dominguez, M. A. Valantin, A. Simon, F. Braicaire, C. Katlama, T. Poynard Groupe Hosp Pitié-Salpêtrière, Paris, France |
| 823 | Impact of Chronic Hepatitis B Infection on Outcomes of HIV-1 Infected Patients Receiving HAART in an Area Hyperendemic for Hepatitis B Infection: An Eight-year Prospective Observational Study W. H. Sheng*1, C. C. Hung1, M. Y. Chen1, S. M. Hsieh1, C. H. Wu1, C. .F Hsiao2 1Natl Taiwan Univ Hosp, Taipei and 2Natl Hlth Res Inst, Taipei, Taiwan |
| 824 | Long-term Tenofovir Treatment of Lamivudine-resistant Chronic Hepatitis B in HIV Co-infected Patients A. G. Marcelin*, R. Tubiana, Y. Benhamou, C. Katlama, V. Calvez, V. Thibault Paris, France |
| 825 | Tenofovir Disoproxil Fumarate and Lamivudine Combination Therapy Compared to Lamivudine Alone for HBV in Therapy-naive HIV/HBV Co-infected Patients: 48-week Interim Results D. Cooper*1, G. Dore1, A. L. Pozniak2, E. DeJesus3, S. Tran4, J. Sayre4, B. Lu4, C. Westland4, M. D. Miller4, D. F. Coakley4, A. Cheng4 1Univ of New South Wales, Sydney, Australia; 2Chelsea and Westminster Hosp, London, UK; 3Infectious Disease Clin Res Initiative, Altamonte Springs, FL; and 4Gilead Sci, Inc, Foster City, CA |
| 826 | Analyzing the Efficacy of Standard Hepatitis A and B Vaccination Schedules in HIV/HCV Co-infected Patients L. E. Taylor1, A. Lai*2, B. Schwartzapfel1, S. E. Reinert1, K. T. Tashima1, J. D. Rich1 1Miriam Hosp, Providence, RI and 2Brown Univ Sch of Med, Providence, RI |